University of Michigan, Kellogg Eye Center
Ann Arbor, Michigan, United States
Eye care center in Ann Arbor, Michigan
1000 Wall St, Ann Arbor, MI 48105
About University of Michigan, Kellogg Eye Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Michigan
13
Neurotech Pharmaceuticals
7
Jaeb Center for Health Research
6
MeiraGTx UK II Ltd
5
Aura Biosciences
3
Hoffmann-La Roche
3
Horizon Pharma USA, Inc.
3
JHSPH Center for Clinical Trials
3
ProQR Therapeutics
3
VisionCare, Inc.
3
Apellis Pharmaceuticals, Inc.
2
Clinical Trials at University of Michigan, Kellogg Eye Center
During the past decade, University of Michigan, Kellogg Eye Center conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 21 clinical trials were completed, i.e. on
average, 39.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
1994-10-01
Unknown status
Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
2003-01-01
2004-05-25
Completed
120
Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk
2007-04-01
2010-11-01
Terminated
368
Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
2007-04-01
2010-01-01
Terminated
122
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
2007-01-01
2010-07-01
Completed
68
A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
2007-01-01
2009-10-01
Completed
65
Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.
2008-12-01
2010-04-01
Completed
326
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Michigan, Kellogg Eye Center" #1 sponsor was "University of Michigan" with 13 trials, followed by "Neurotech Pharmaceuticals" with 7 trials
sponsored, "Jaeb Center for Health Research" with 6 trials sponsored, "MeiraGTx UK II Ltd" with 5 trials sponsored and "Aura Biosciences"
with 5 trials sponsored. Other sponsors include 42 different institutions and
companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan, Kellogg Eye Center"
#1 collaborator was "National Eye Institute (NEI)" with 10 trials as a collaborator, "Foundation Fighting Blindness" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator and "The Lowy Medical Research Institute Limited" with 2 trials as a collaborator. Other collaborators include 46 different institutions and companies that were
collaborators in the rest 55 trials.
Clinical Trials Conditions at University of Michigan, Kellogg Eye Center
According to Clinical.Site data, the most researched conditions in "University of Michigan, Kellogg Eye Center" are
"Retinitis Pigmentosa" (11 trials), "Eye Diseases" (5 trials), "Eye Diseases, Hereditary" (5 trials), "Eye Disorders Congenital" (4 trials) and "Macular Telangiectasia Type 2" (4 trials). Many other conditions were trialed in "University of Michigan, Kellogg Eye Center" in a lesser frequency.
Clinical Trials Intervention Types at University of Michigan, Kellogg Eye Center
Most popular intervention types in "University of Michigan, Kellogg Eye Center" are "Drug" (38 trials), "Device" (13 trials), "Biological" (12 trials), "Other" (11 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "NT-501" (3 trials), "Ciliary neurotrophic factor (CNTF)" (2 trials), "LX201" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University of Michigan, Kellogg Eye Center
The vast majority of trials in "University of Michigan, Kellogg Eye Center" are
74 trials for "All" genders, 6 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at University of Michigan, Kellogg Eye Center
Currently, there are 27 active trials in "University of Michigan, Kellogg Eye Center".
2 are not yet recruiting,
11 are recruiting,
13 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 39 completed trials in University of Michigan, Kellogg Eye Center,
undefined suspended trials,
and 11 terminated clinical trials to date.
Out of the total trials that were conducted in University of Michigan, Kellogg Eye Center, 11 "Phase 1"
clinical trials were conducted, 29 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 8 trials that are defined as “Not Applicable".